• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用现有测序技术和生物信息学方法揭示原发性和转移性犬附肢骨肉瘤的混沌基因组图谱。

Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.

机构信息

Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, United States of America.

McDonnell Genome Institute, Washington University, St. Louis, MO, United States of America.

出版信息

PLoS One. 2021 Feb 8;16(2):e0246443. doi: 10.1371/journal.pone.0246443. eCollection 2021.

DOI:10.1371/journal.pone.0246443
PMID:33556121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7870011/
Abstract

Osteosarcoma is a rare disease in children but is one of the most common cancers in adult large breed dogs. The mutational landscape of both the primary and pulmonary metastatic tumor in two dogs with appendicular osteosarcoma (OSA) was comprehensively evaluated using an automated whole genome sequencing, exome and RNA-seq pipeline that was adapted for this study for use in dogs. Chromosomal lesions were the most common type of mutation. The mutational landscape varied substantially between dogs but the lesions within the same patient were similar. Copy number neutral loss of heterozygosity in mutant TP53 was the most significant driver mutation and involved a large region in the middle of chromosome 5. Canine and human OSA is characterized by loss of cell cycle checkpoint integrity and DNA damage response pathways. Mutational profiling of individual patients with canine OSA would be recommended prior to targeted therapy, given the heterogeneity seen in our study and previous studies.

摘要

骨肉瘤在儿童中较为罕见,但在成年大型犬中却是最常见的癌症之一。本研究采用一种自动化全基因组测序、外显子组和 RNA-seq 分析流程,对两只患有附肢骨肉瘤(OSA)的犬的原发性和肺转移肿瘤进行了全面评估。结果显示,染色体病变是最常见的突变类型。尽管不同犬种的突变景观存在显著差异,但同一患者的病变却较为相似。在突变型 TP53 中,杂合性缺失是最重要的驱动突变,涉及染色体 5 中部的一个大片段。犬类和人类的骨肉瘤的特点是细胞周期检查点完整性和 DNA 损伤反应途径的丧失。鉴于本研究和以往研究中观察到的异质性,建议在对犬类 OSA 患者进行靶向治疗之前,对其进行突变分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/b34656427ecf/pone.0246443.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/24246c9c07a9/pone.0246443.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/976dc20d179b/pone.0246443.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/b34656427ecf/pone.0246443.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/24246c9c07a9/pone.0246443.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/976dc20d179b/pone.0246443.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25c1/7870011/b34656427ecf/pone.0246443.g003.jpg

相似文献

1
Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches.利用现有测序技术和生物信息学方法揭示原发性和转移性犬附肢骨肉瘤的混沌基因组图谱。
PLoS One. 2021 Feb 8;16(2):e0246443. doi: 10.1371/journal.pone.0246443. eCollection 2021.
2
TP53 gene mutations in canine osteosarcoma.犬骨肉瘤中的TP53基因突变
Vet Surg. 2008 Jul;37(5):454-60. doi: 10.1111/j.1532-950X.2008.00407.x.
3
Evaluation of P16 expression in canine appendicular osteosarcoma.犬附肢骨肉瘤中P16表达的评估
BMC Vet Res. 2017 Jun 20;13(1):189. doi: 10.1186/s12917-017-1113-5.
4
Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.犬骨肉瘤:一种用于为儿科肿瘤学提供信息的自然发生的疾病。
ILAR J. 2014;55(1):69-85. doi: 10.1093/ilar/ilu009.
5
P53 gene mutations in osteosarcomas in the dog.犬骨肉瘤中的P53基因突变
Cancer Lett. 1997 Jan 1;111(1-2):173-8. doi: 10.1016/s0304-3835(96)04529-6.
6
The animal-dependent risk factors in canine osteosarcomas.犬骨肉瘤中与动物相关的危险因素。
Pol J Vet Sci. 2017 Mar 1;20(2):293-298. doi: 10.1515/pjvs-2017-0035.
7
Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.应用 array-CGH 和 RT-qPCR 对犬骨肉瘤进行特征分析:犬骨肉瘤的基因组失衡特征与人骨肉瘤相似。
Genes Chromosomes Cancer. 2011 Nov;50(11):859-74. doi: 10.1002/gcc.20908. Epub 2011 Aug 11.
8
Status of the p53, Rb and MDM2 genes in canine osteosarcoma.犬骨肉瘤中p53、Rb和MDM2基因的状态
Anticancer Res. 1998 Nov-Dec;18(6A):4449-53.
9
Investigating CXCR4 expression in canine appendicular osteosarcoma.研究犬附肢骨肉瘤中CXCR4的表达情况。
J Vet Intern Med. 2008 May-Jun;22(3):602-8. doi: 10.1111/j.1939-1676.2008.0089.x. Epub 2008 May 2.
10
Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog.犬自发性骨肉瘤中p53肿瘤抑制基因的突变
Carcinogenesis. 1998 Jan;19(1):213-7. doi: 10.1093/carcin/19.1.213.

引用本文的文献

1
Internalisation of the SDGs in the Western Brazilian Amazon: a qualitative study on continuing education processes and health vulnerability.巴西西部亚马逊地区可持续发展目标的内化:关于继续教育过程与健康脆弱性的定性研究
Int J Equity Health. 2025 Jun 13;24(1):173. doi: 10.1186/s12939-025-02484-5.
2
Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma.犬口腔骨肉瘤基因组图谱的特征揭示了其与四肢骨肉瘤的相似性。
PLoS One. 2025 Jun 10;20(6):e0325181. doi: 10.1371/journal.pone.0325181. eCollection 2025.
3
Comprehensive Analysis of Microsatellite Instability in Canine Cancers: Implications for Comparative Oncology and Personalized Veterinary Medicine.

本文引用的文献

1
Molecular Characterisation of Canine Osteosarcoma in High Risk Breeds.高危犬种骨肉瘤的分子特征
Cancers (Basel). 2020 Aug 25;12(9):2405. doi: 10.3390/cancers12092405.
2
A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants.全面评估原发性皮肤黑色素瘤中的致病突变,包括鉴定新的功能丧失变异。
Sci Rep. 2019 Nov 19;9(1):17050. doi: 10.1038/s41598-019-53636-x.
3
Pan-cancer whole-genome analyses of metastatic solid tumours.泛癌种实体瘤全基因组分析。
犬类癌症中微卫星不稳定性的综合分析:对比较肿瘤学和个性化兽医学的启示
Animals (Basel). 2024 Aug 27;14(17):2484. doi: 10.3390/ani14172484.
4
Bringing the Genomic Revolution to Comparative Oncology: Human and Dog Cancers.将基因组革命引入比较肿瘤学:人类癌症和犬类癌症。
Annu Rev Biomed Data Sci. 2024 Aug;7(1):107-129. doi: 10.1146/annurev-biodatasci-102423-111936. Epub 2024 Jul 24.
5
Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma.新辅助唑来膦酸与放射治疗对犬骨肉瘤细胞存活、细胞周期分布及临床状态的影响
Front Vet Sci. 2024 Jan 31;11:1237084. doi: 10.3389/fvets.2024.1237084. eCollection 2024.
6
Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology.引领潮流:比较犬类癌症基因组学的最佳实践,为人类肿瘤学提供信息。
Vet Comp Oncol. 2023 Dec;21(4):565-577. doi: 10.1111/vco.12935. Epub 2023 Oct 1.
7
Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships.自然发生的犬类肉瘤:通过跨学科研究合作弥合从小鼠模型到人类患者的差距。
Front Oncol. 2023 Mar 23;13:1130215. doi: 10.3389/fonc.2023.1130215. eCollection 2023.
8
The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.犬骨肉瘤细胞系的基因组景观揭示了保守的结构复杂性和通路改变。
PLoS One. 2022 Sep 13;17(9):e0274383. doi: 10.1371/journal.pone.0274383. eCollection 2022.
9
Characterizing the metabolic role of STAT3 in canine osteosarcoma.解析 STAT3 在犬骨肉瘤中的代谢作用。
Vet Comp Oncol. 2022 Dec;20(4):817-824. doi: 10.1111/vco.12841. Epub 2022 Jul 11.
Nature. 2019 Nov;575(7781):210-216. doi: 10.1038/s41586-019-1689-y. Epub 2019 Oct 23.
4
Canine osteosarcoma genome sequencing identifies recurrent mutations in and the histone methyltransferase gene .犬骨肉瘤基因组测序鉴定出 和组蛋白甲基转移酶基因 的反复突变。
Commun Biol. 2019 Jul 19;2:266. doi: 10.1038/s42003-019-0487-2. eCollection 2019.
5
Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review.犬类和人类骨肉瘤发生的风险因素:一项比较性综述。
Vet Sci. 2019 May 25;6(2):48. doi: 10.3390/vetsci6020048.
6
MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.MITF 表达预测人类黑色素瘤对 p300 抑制的治疗易感性。
Cancer Res. 2019 May 15;79(10):2649-2661. doi: 10.1158/0008-5472.CAN-18-2331. Epub 2019 Mar 25.
7
Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.钙黏蛋白11抑制可下调β-连环蛋白,使经典WNT信号通路失活,并抑制三阴性乳腺癌的癌症干细胞样表型。
J Clin Med. 2019 Jan 27;8(2):148. doi: 10.3390/jcm8020148.
8
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.使用配对的肿瘤和正常样本进行测序数据体细胞变异细化的标准操作程序。
Genet Med. 2019 Apr;21(4):972-981. doi: 10.1038/s41436-018-0278-z. Epub 2018 Oct 5.
9
Genome-Informed Targeted Therapy for Osteosarcoma.基于基因组信息的骨肉瘤靶向治疗。
Cancer Discov. 2019 Jan;9(1):46-63. doi: 10.1158/2159-8290.CD-17-1152. Epub 2018 Sep 28.
10
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.采用全基因组、全外显子组和转录组三平台测序对癌症进行临床基因组分析。
Nat Commun. 2018 Sep 27;9(1):3962. doi: 10.1038/s41467-018-06485-7.